Annapolis Internal Medicine is excited to announce a new clinical trial for patients with Type 2 diabetes. People recently diagnosed with Type 2 diabetes are at higher risk for developing pancreatic cancer.
Bluestar Genomics is studying a new blood test to identify pancreatic cancer in people with recently
diagnosed Type 2 diabetes.
You may be a candidate for this research study if the following apply:
- You are 50 years of age or older
- You’ve recently been diagnosed with Type 2 diabetes within 6 months
If you’re interested in participating in this clinical trial, contact Annapolis Internal Medicine today for more information. Check out the link below for more details on the trial.